Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jan Krhut, Barbora Skugarevská, David Míka, Lars Lund & Peter Zvara. (2022) Clinical Utility of β3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations. Research and Reports in Urology 14, pages 167-175.
Read now
Read now
Articles from other publishers (2)
Stefan de Vogel, John D. Seeger, Alejandro Arana, Andrea V. Margulis, Lisa J. McQuay, Susana Perez‐Gutthann, Jesper Hallas, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng & Noah Jamie Robinson. (2024) Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program. Pharmacoepidemiology and Drug Safety 33:5.
Crossref
Crossref
Cathrine Axfors, Chirag J. Patel & John P.A. Ioannidis. (2023) Published registry-based pharmacoepidemiologic associations show limited concordance with agnostic medication-wide analyses. Journal of Clinical Epidemiology 160, pages 33-45.
Crossref
Crossref